![Michael S. Paul](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Michael S.
Paul is a President, Chief Executive Officer & Director at MARA Bio Systems, Inc. He is on the Board of Directors at MARA Bio Systems, Inc. Dr. Paul was previously employed as a Chief Strategy Officer by Bionano Genomics, Inc., a President, Chief Executive Officer & Director by Lineagen, Inc., a Vice President-Business Development by Huntsman International LLC, a Venture Partner by Mesa Verde Ventures LLC, a Director-Strategic Development by NPS Pharmaceuticals, Inc., a Principal by University of Utah, and a Venture Partner by vSpring Capital LLC.
He received his undergraduate degree from Colby College and a doctorate degree from the University of Utah.
| Unternehmen | Position | Beginn |
|---|---|---|
MARABio Systems, Inc.
 MARABio Systems, Inc. Medical SpecialtiesHealth Technology Manufactures testing products for autism | Vorstandsvorsitzender | 17.04.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
vSpring Capital LLC
 vSpring Capital LLC Investment ManagersFinance vSpring Capital focuses on seed and early-stage investments in information technology and life sciences companies located in the Rocky Mountain region of the US. The firm also opportunistically invests in later-stage companies under special circumstances. They look for companies that have the potential to become significant stand-alone businesses. When considering a potential investment, vSpring Capital considers the company's potential for capital appreciation. The firm seeks companies with exceptional management teams, large markets and barriers to entry. Companies should also have a business model with the potential for large margins and significant free cash flow, and a reasonable valuation at the time of investment that will provide a substantial return-on-investment opportunity commensurate with risk. Investments range from $250,000 to $5 million. vSpring Capital typically makes initial investments of $2 million to $3 million, with the expectation of investing up to $5 million over the life of a company | Private Equity Investor | 31.05.2011 |
Mesa Verde Ventures LLC
 Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures invests in companies located in the United States primarily in California and the Southwest. The firm seeks investment opportunities in biotechnology and medical technology companies. It provides financing for early stage capital requirements. | Corporate Officer/Principal | 01.06.2010 |
| BIONANO GENOMICS, INC. | Corporate Officer/Principal | - |
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Huntsman International LLC
 Huntsman International LLC Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 9 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
Huntsman International LLC
Huntsman International LLC Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | Finance |
Mesa Verde Ventures LLC
Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures invests in companies located in the United States primarily in California and the Southwest. The firm seeks investment opportunities in biotechnology and medical technology companies. It provides financing for early stage capital requirements. | Finance |
Lineagen, Inc.
 Lineagen, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic evaluation services | Health Services |
vSpring Capital LLC
vSpring Capital LLC Investment ManagersFinance vSpring Capital focuses on seed and early-stage investments in information technology and life sciences companies located in the Rocky Mountain region of the US. The firm also opportunistically invests in later-stage companies under special circumstances. They look for companies that have the potential to become significant stand-alone businesses. When considering a potential investment, vSpring Capital considers the company's potential for capital appreciation. The firm seeks companies with exceptional management teams, large markets and barriers to entry. Companies should also have a business model with the potential for large margins and significant free cash flow, and a reasonable valuation at the time of investment that will provide a substantial return-on-investment opportunity commensurate with risk. Investments range from $250,000 to $5 million. vSpring Capital typically makes initial investments of $2 million to $3 million, with the expectation of investing up to $5 million over the life of a company | Finance |
University of Utah
University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Colby College
 Colby College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bionano Genomics, Inc.
 Bionano Genomics, Inc. BiotechnologyHealth Technology Develops technologies for analysis of large biological molecules | Health Technology |
MARABio Systems, Inc.
MARABio Systems, Inc. Medical SpecialtiesHealth Technology Manufactures testing products for autism | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
